title: The impact of microbiota on brain and behavior: mechanisms & therapeutic potential.
abstract: There is increasing evidence that host-microbe interactions play a key role in maintaining homeostasis. Alterations in gut microbial composition is associated with marked changes in behaviors relevant to mood, pain and cognition, establishing the critical importance of the bi-directional pathway of communication between the microbiota and the brain in health and disease. Dysfunction of the microbiome-brain-gut axis has been implicated in stress-related disorders such as depression, anxiety and irritable bowel syndrome and neurodevelopmental disorders such as autism. Bacterial colonization of the gut is central to postnatal development and maturation of key systems that have the capacity to influence central nervous system (CNS) programming and signaling, including the immune and endocrine systems. Moreover, there is now expanding evidence for the view that enteric microbiota plays a role in early programming and later response to acute and chronic stress. This view is supported by studies in germ-free mice and in animals exposed to pathogenic bacterial infections, probiotic agents or antibiotics. Although communication between gut microbiota and the CNS are not fully elucidated, neural, hormonal, immune and metabolic pathways have been suggested. Thus, the concept of a microbiome-brain-gut axis is emerging, suggesting microbiota-modulating strategies may be a tractable therapeutic approach for developing novel treatments for CNS disorders.
authors.affiliation: Laboratory of NeuroGastroenterology, Alimentary Pharmabiotic Centre, University College Cork, Cork, Ireland.
authors.forename: Yuliya E
authors.initials: YE
authors.lastname: Borre
authors.forename: Rachel D
authors.initials: RD
authors.lastname: Moloney
authors.forename: Gerard
authors.initials: G
authors.lastname: Clarke
authors.forename: Timothy G
authors.initials: TG
authors.lastname: Dinan
authors.forename: John F
authors.initials: JF
authors.lastname: Cryan
mesh_terms: D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D001519:Behavior; D001921:Brain / Q000502:physiology*; D001927:Brain Diseases / Q000628:therapy; D003071:Cognition; D006801:Humans; D007422:Intestines / Q000382:microbiology; D064307:Microbiota / Q000502:physiology*; D019936:Probiotics / Q000494:pharmacology; D015398:Signal Transduction; D014364:Tryptophan / Q000378:metabolism
chemical_list: D000900:Anti-Bacterial Agents; D014364:Tryptophan